CATO 佳途CATO · CNAS + ANAB ISO 17034 双体系认可标准物质生产者CNAS + ANAB ISO 17034 dual-accredited reference material producer
销售顾问Sales contact 卢振明Kaka Lu+86 185 2048 1969kaka@cato-chem.com
Danazol

达那唑 杂质对照品Danazol Impurities

35 个杂质条目35 impurity entries

本页汇总 达那唑 的 35 个杂质对照品条目。杂质谱是仿制药杂质研究、方法开发与稳定性考察的起点——先锁定品种,再逐条比对结构差异与保留行为。This page collects 35 impurity reference standards of Danazol. The impurity profile is the starting point for related-substance method development, forced degradation and stability studies.

批量索取报价 / COABulk quote / COA在全站目录中检索Search the full catalogue

相关研究文献Related literature

以下为 达那唑(Danazol)在公开文献中的研究报道(题录信息,来源 PubMed),供方法开发与文献调研参考。Selected peer-reviewed publications on this drug substance — bibliographic records from PubMed.

  1. 杂质研究Impurity studiesPhotodegradation kinetic study and stability-indicating assay of danazol using high-performance liquid chromatography
    Journal of pharmaceutical and biomedical analysis · 2000 · Kariem EA et al.  ·  PMID 10933534  ·  DOI
  2. 杂质研究Impurity studiesEstimation of impurity profiles of drugs and related materials. 12. Isolation and identification of an isomeric impurity in danazol
    Pharmaceutical research · 1995 · Balogh G et al.  ·  PMID 7784348  ·  DOI
  3. 杂质研究Impurity studiesEffects of alkali and simulated gastric and intestinal fluids on danazol stability
    Journal of pharmaceutical and biomedical analysis · 2003 · Gadkariem EA et al.  ·  PMID 12644201  ·  DOI
  4. 分析方法Analytical MethodsConventional and micellar liquid chromatography method development for danazol and validation in capsules
    Journal of pharmaceutical and biomedical analysis · 2003 · Gonzalo-Lumbreras R, Izquierdo-Hornillos R  ·  PMID 14565547  ·  DOI
  5. 分析方法Analytical MethodsMiniaturized ionic liquid dispersive liquid-liquid microextraction in a coupled-syringe system combined with UV for extraction and determination of danazol in danazol capsule and mice serum
    Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy · 2016 · Gong A, Zhu X  ·  PMID 26845583  ·  DOI

达那唑 —— 原料药与杂质对照品Danazol — drug substance & impurities

共 35 个条目(含原料药本体)35 items incl. the drug substance
Danazol Impurity 1 structure
1
达那唑杂质1Danazol Impurity 1
Danazol Impurity 1
CAS No.2787-02-2
Chemical FormulaC22H28O3
Purity>95%询价On request
10mg25mg50mg100mg
Danazol Impurity 2 structure
2
达那唑杂质2Danazol Impurity 2
Danazol Impurity 2
CAS No.161696-95-3
Chemical FormulaC22H27NO2
Purity>95%询价On request
10mg25mg50mg100mg
Danazol Impurity 3 structure
3
达那唑杂质3Danazol Impurity 3
Danazol Impurity 3
CAS No.80651-65-6
Chemical FormulaC20H29NO2
Purity>95%询价On request
10mg25mg50mg100mg
Danazol Impurity 4 structure
4
达那唑杂质4Danazol Impurity 4
Danazol Impurity 4
CAS No.2137-41-9
Chemical FormulaC22H28O2
Purity>95%询价On request
10mg25mg50mg100mg
Danazol Impurity 5 structure
5
达那唑杂质5Danazol Impurity 5
Danazol Impurity 5
CAS No.875218-97-6
Chemical FormulaC22H27NO2
Purity>95%询价On request
10mg25mg50mg100mg
Danazol Impurity 6 structure
6
达那唑杂质6Danazol Impurity 6
Danazol Impurity 6
CAS No.1204736-18-4
Chemical FormulaC22H27NO2
Purity>95%询价On request
10mg25mg50mg100mg
Danazol Impurity 7 structure
7
达那唑杂质7Danazol Impurity 7
Danazol Impurity 7
CAS No.100931-47-3
Chemical FormulaC23H29NO2
Purity>95%询价On request
10mg25mg50mg100mg
Danazol Impurity 8 structure
8
达那唑杂质8Danazol Impurity 8
Danazol Impurity 8
CAS No.885120-26-3
Chemical FormulaC23H29NO2
Purity>95%询价On request
10mg25mg50mg100mg
Danazol Impurity 9 structure
9
达那唑杂质9Danazol Impurity 9
Danazol Impurity 9
CAS No.71507-23-8
Chemical FormulaC23H29NO2
Purity>95%询价On request
10mg25mg50mg100mg
Danazol Impurity 10 structure
10
达那唑杂质10Danazol Impurity 10
Danazol Impurity 10
CAS No.1850281-04-7
Chemical FormulaC22H27NO3
Purity>95%询价On request
10mg25mg50mg100mg
Danazol Impurity 11 structure
11
达那唑杂质11Danazol Impurity 11
Danazol Impurity 11
CAS No.13634-73-6
Chemical FormulaC23H27NO2
Purity>95%询价On request
10mg25mg50mg100mg
Danazol Impurity 12 structure
12
达那唑杂质12Danazol Impurity 12
Danazol Impurity 12
CAS No.1850281-03-6
Chemical FormulaC22H27NO3
Purity>95%询价On request
10mg25mg50mg100mg
Danazol Impurity 13 structure
13
达那唑杂质13Danazol Impurity 13
Danazol Impurity 13
CAS No.121565-23-9
Chemical FormulaC22H26ClNO2
Purity>95%询价On request
10mg25mg50mg100mg
Danazol Impurity 14 structure
14
达那唑杂质14Danazol Impurity 14
Danazol Impurity 14
CAS No.143137-15-9
Chemical FormulaC28H31NO2
Purity>95%询价On request
10mg25mg50mg100mg
Danazol Impurity 15 structure
15
达那唑杂质15Danazol Impurity 15
Danazol Impurity 15
CAS No.143137-28-4
Chemical FormulaC26H29NO2S
Purity>95%询价On request
10mg25mg50mg100mg
Danazol Impurity 16 structure
16
达那唑杂质16Danazol Impurity 16
Danazol Impurity 16
CAS No.65969-02-0
Chemical FormulaC23H26F3NO2
Purity>95%询价On request
10mg25mg50mg100mg
Danazol Impurity 17 structure
17
达那唑杂质17Danazol Impurity 17
Danazol Impurity 17
CAS No.143137-24-0
Chemical FormulaC28H30FNO2
Purity>95%询价On request
10mg25mg50mg100mg
Danazol Impurity 18 structure
18
达那唑杂质18Danazol Impurity 18
Danazol Impurity 18
CAS No.108333-26-2
Chemical FormulaC24H29NO3
Purity>95%询价On request
10mg25mg50mg100mg
Danazol Impurity 19 structure
19
达那唑杂质19Danazol Impurity 19
Danazol Impurity 19
CAS No.143137-25-1
Chemical FormulaC27H30N2O2
Purity>95%询价On request
10mg25mg50mg100mg
Danazol Impurity 20 structure
20
达那唑杂质20Danazol Impurity 20
Danazol Impurity 20
CAS No.108333-27-3
Chemical FormulaC25H31NO3
Purity>95%询价On request
10mg25mg50mg100mg
Danazol Impurity 21 structure
21
达那唑杂质21Danazol Impurity 21
Danazol Impurity 21
CAS No.143137-27-3
Chemical FormulaC28H30N2O4
Purity>95%询价On request
10mg25mg50mg100mg
Danazol Impurity 22 structure
22
达那唑杂质22Danazol Impurity 22
Danazol Impurity 22
CAS No.162070-23-7
Chemical FormulaC24H30N2O3
Purity>95%询价On request
10mg25mg50mg100mg
Danazol Impurity 23 structure
23
达那唑杂质23Danazol Impurity 23
Danazol Impurity 23
CAS No.108333-28-4
Chemical FormulaC29H39NO3
Purity>95%询价On request
10mg25mg50mg100mg
Danazol Impurity 24 structure
24
达那唑杂质24Danazol Impurity 24
Danazol Impurity 24
CAS No.108333-29-5
Chemical FormulaC33H47NO3
Purity>95%询价On request
10mg25mg50mg100mg
Danazol Impurity 25 structure
25
达那唑杂质25Danazol Impurity 25
Danazol Impurity 25
CAS No.143137-26-2
Chemical FormulaC29H30F3NO2
Purity>95%询价On request
10mg25mg50mg100mg
Danazol Impurity 26 structure
26
达那唑杂质26Danazol Impurity 26
Danazol Impurity 26
CAS No.1255648-46-4
Chemical FormulaC26H31NO5
Purity>95%询价On request
10mg25mg50mg100mg
Danazol Impurity 27 structure
27
达那唑杂质27Danazol Impurity 27
Danazol Impurity 27
CAS No.162070-24-8
Chemical FormulaC25H32N2O3
Purity>95%询价On request
10mg25mg50mg100mg
Danazol Impurity 28 structure
28
达那唑杂质28Danazol Impurity 28
Danazol Impurity 28
CAS No.1204736-19-5
Chemical FormulaC26H31NO5
Purity>95%询价On request
10mg25mg50mg100mg
Danazol Impurity 29 structure
29
达那唑杂质29Danazol Impurity 29
Danazol Impurity 29
CAS No.117204-93-0
Chemical FormulaC25H31NO4
Purity>95%询价On request
10mg25mg50mg100mg
Danazol Impurity 30 structure
30
达那唑杂质30Danazol Impurity 30
Danazol Impurity 30
CAS No.917393-81-8
Chemical FormulaC26H34N2O4
Purity>95%询价On request
10mg25mg50mg100mg
Danazol Impurity 31 structure
31
达那唑杂质31Danazol Impurity 31
Danazol Impurity 31
CAS No.162070-22-6
Chemical FormulaC28H39N3O3
Purity>95%询价On request
10mg25mg50mg100mg
Danazol Impurity 32 structure
32
达那唑杂质32Danazol Impurity 32
Danazol Impurity 32
CAS No.1278592-56-5
Chemical FormulaC29H40N2O4
Purity>95%询价On request
10mg25mg50mg100mg
Danazol Impurity 33 structure
33
达那唑杂质33Danazol Impurity 33
Danazol Impurity 33
CAS No.913339-64-7
Chemical FormulaC27H34N2O3
Purity>95%询价On request
10mg25mg50mg100mg
Danazol Impurity 34 structure
34
达那唑杂质34Danazol Impurity 34
Danazol Impurity 34
CAS No.304462-71-3
Chemical FormulaC28H37NO7
Purity>95%询价On request
10mg25mg50mg100mg
Danazol Impurity 35 structure
35
达那唑杂质35Danazol Impurity 35
Danazol Impurity 35
CAS No.1278592-55-4
Chemical FormulaC29H39N3O5
Purity>95%询价On request
10mg25mg50mg100mg

结构式清晰度以随货 COA 与厂家图谱为准;目录之外的杂质可按需定制合成或调取。Structural confirmation is governed by the COA and manufacturer spectra. Impurities outside this list can be custom-synthesised or sourced on request.

Literature & synthesis

达那唑 —— 研究文献与合成路线Danazol — literature & synthetic routes

以下题录由公开学术数据库按品种名检索汇总,供 达那唑 的杂质谱研究、分析方法开发与工艺路线选择参考。文献题名与专利标题均可点击查看原文,版权归原作者与出版方所有。Citations below are aggregated from public scholarly databases by drug-substance name, for reference in impurity profiling, analytical method development and route selection for Danazol. Titles link to the original records; copyright remains with the authors and publishers.

杂质与降解研究文献Impurity & degradation studies

  1. Photodegradation kinetic study and stability-indicating assay of danazol using high-performance liquid chromatography
    Kariem EA, Abounassif MA, Hagga ME, et al. · Journal of pharmaceutical and biomedical analysis · 2000 · 被引 17cited 17
  2. Estimation of impurity profiles of drugs and related materials. 12. Isolation and identification of an isomeric impurity in danazol
    Balogh G, Csizér E, Ferenczy GG, et al. · Pharmaceutical research · 1995 · 被引 14cited 14
  3. Determination of danazol in pharmaceutical preparations by liquid chromatography
    Sane RT, Chakraborty M, Nayak VG, et al. · Journal of chromatography · 1986 · 被引 7cited 7

合成与制备工艺专利Synthesis & process patents

  1. Intra-uterus administered medicinal stick of danazol and preparation process thereof
    LIN JUN ZHANG · 公开号 CN1965842CN1965842 · 2007
  2. Method of preparing ultra-fine danazol powder
    JIANFENG CHEN, HONG ZHAO, JIEXIN WANG, ZHIGANG SHEN, et al. · 公开号 CN101292958CN101292958 · 2008

题录与链接来自公开数据库 Europe PMC(含 PubMed 与全球专利题录)与 WIPO PatentScope,本站仅提供索引,不转载正文;如链接失效请以数据库检索为准。Citations are indexed from public databases (Europe PMC incl. PubMed and patent records, WIPO PatentScope); we provide links only and do not reproduce full text.

For formulation & analytical R&D

达那唑 杂质谱研究要点Danazol — impurity profiling notes

下面这些是拿到 达那唑 的 35 个杂质条目之后,仿制药研发最常遇到的几件事。先把杂质的来源分清,再决定要不要买对照品、买哪几个。Once you have the 35 impurity entries for Danazol, these are the questions that come up most in generic development. Classify the source of each impurity first, then decide which reference standards you actually need.

01工艺杂质Process impurities

起始物料、中间体、副产物、催化剂与溶剂残留。多来自合成路线本身,应在工艺开发阶段用加标试验定位。Starting materials, intermediates, by-products, catalysts and residual solvents — traced back to the synthetic route and located with spiking studies during process development.

02降解杂质Degradation impurities

水解、氧化、光解、高温高湿与聚合产物。需通过强制降解试验识别,并确认方法具备稳定性指示能力。Hydrolytic, oxidative, photolytic, thermal and polymeric degradants — identified through forced degradation, with the method proven stability-indicating.

03药典杂质Pharmacopoeial impurities

EP/USP 已收载并有官方编号的杂质(如 EP Impurity A、USP Related Compound B)。申报时通常需逐项对照。Impurities already monographed with official designations (e.g. EP Impurity A, USP Related Compound B), normally compared item by item during filing.

04基因毒性杂质Genotoxic impurities

含警示结构、需按 ICH M7 进行危害评估与限度推导(TTC 1.5 µg/日)。该类杂质必须用对照品准确控制。Structurally alerting compounds requiring ICH M7 hazard assessment and limit derivation (TTC 1.5 µg/day); these must be controlled with an authentic reference standard.

05同位素标记物Isotopically labelled standards

氘代、¹³C、¹⁵N 标记的同类物,主要用作 LC-MS/MS 生物分析的内标,抵消基质效应与回收率波动。Deuterated, ¹³C- and ¹⁵N-labelled analogues used as internal standards in LC-MS/MS bioanalysis to compensate matrix effects and recovery variation.

06代谢与转化产物Metabolites & conversion products

体内代谢物、强制降解转化物与工艺中间态,常见于杂质谱比对与稳定性考察中。In-vivo metabolites, forced-degradation products and process intermediates encountered in impurity profiling and stability studies.

方法开发与对照品使用建议Method development and standards usage

先定分离,再谈定量Resolution first, then quantification

主成分与相邻杂质峰分离度应 ≥1.5;用杂质对照品确定相对保留时间与相对响应因子,避免用自身对照法掩盖响应差异。Target baseline resolution ≥1.5 between the main component and adjacent impurities; establish relative retention and relative response factors with authentic impurity standards rather than relying on self-comparison.

校正因子不可忽略Never ignore response factors

紫外吸收差异大的杂质必须校正,否则定量结果系统性偏低或偏高。EP/USP 已给出校正因子的按药典执行。Impurities with markedly different UV response need correction, otherwise results are systematically biased. Where EP/USP publish a correction factor, follow the monograph.

强制降解要做全Run the full forced-degradation panel

建议覆盖酸、碱、氧化(H₂O₂)、光照(ICH Q1B)、高温高湿;主峰纯度用二极管阵列或质谱确认。Cover acid, base, peroxide oxidation, photostability (ICH Q1B) and heat/humidity; confirm peak purity by DAD or MS.

定义报告阈值Set reporting and identification thresholds

按 ICH Q3A/Q3B 设定报告阈值、鉴定阈值与界定阈值,避免为无意义的峰投入过多工作量。Apply ICH Q3A/Q3B reporting, identification and qualification thresholds so effort is not spent on insignificant peaks.

标准品储存有讲究Store standards properly

杂质对照品多建议 −20 ℃ 避光、干燥、密封保存;溶液现配现用,并记录开瓶与配制日期。Most impurity standards should be stored at −20 °C, protected from light and moisture; prepare solutions fresh and record opening and preparation dates.

用结构式先做初判Start from the structure

先比对杂质与主成分的结构差异,可预判其保留行为、紫外响应与可能的降解路径,能显著减少试错。Comparing the impurity structure with the parent drug predicts retention behaviour, UV response and probable degradation routes, cutting trial and error.

以上为通行的杂质研究实践提示,不针对具体品种给出结论。实际限度、校正因子与色谱条件请以 EP/USP 各论及你们的验证数据为准。需要某个杂质的结构确证资料、COA 或定制合成,可直接联系我们。The above are general impurity-profiling notes and are not conclusions about this specific drug substance. Actual limits, correction factors and chromatographic conditions follow the EP/USP monograph and your own validation data. Contact us for structural confirmation data, COAs or custom synthesis.
索取杂质谱报价 / COARequest a quote / COA← 查看其它品种← Other drug substances